Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

CTAG vs. APSDX: which is better?

Bottom line

CTAG vs APSDX: the short answer

CTAG (Calamos Timpani Active SMID Growth ETF) and APSDX (NYLI Fiera SMID Growth Fund) are both etfs.

Updated Nov 19, 2026

CTAG vs APSDX side by side

CTAGAPSDX
TypeETFMutual fund
Fund familyCalamosNew York Life Investments
CategorySmall-CapSmall-Cap
Expense ratio—0.82%
Annual cost per $10k—$82
10-yr cost on $10k (prospectus)—$1,014
Max front loadNone0%
12b-1 fee—0%
1-yr return—+5.8%
5-yr return (annualized)——
10-yr return (annualized)——
Best quarter——
Worst quarter——
Net assets (fund)—$201.4M
Number of holdings—79
Portfolio turnover—5%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

CTAG and APSDX share none of their top holdings.

CTAG top 10

    APSDX top 10

    1. JFrog Ltd. — 3.71%
    2. BWX Technologies, Inc. — 2.63%
    3. EMCOR Group, Inc. — 2.40%
    4. Neurocrine Biosciences, Inc. — 2.27%
    5. Stifel Financial Corp. — 2.23%
    6. MongoDB, Inc. — 2.12%
    7. Argenx SE — 2.09%
    8. Insmed, Inc. — 2.04%
    9. Expedia Group, Inc. — 2.00%
    10. Lattice Semiconductor Corp. — 1.97%

    FAQ

    What is the difference between CTAG and APSDX?
    CTAG (Calamos Timpani Active SMID Growth ETF) and APSDX (NYLI Fiera SMID Growth Fund) are both etfs.
    Should I own both CTAG and APSDX?
    Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

    Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.